Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Epimedium brevicornum (Icariin).
Icariin functions as a prenylated flavonol glycoside that exerts phosphodiesterase type 5 (PDE5) inhibition and promotes osteogenic differentiation through the activation of the Wnt/beta-catenin signaling pathway.
5318997
676.7 g/mol
1.7
5-hydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxychromen-4-one
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Epimedium brevicornum (Icariin) across standard consumer modalities.
High-purity icariin extracts are notably hygroscopic, requiring low-moisture HPMC shells and desiccants to prevent powder caking and oxidation.
The intense bitterness and astringency of prenylated flavonoids require advanced organoleptic masking and can destabilize pectin-based matrices at high inclusion rates.
The typical therapeutic dosage of Epimedium extract significantly exceeds the 50mg payload limit of standard thin-film polymers, necessitating high-potency standardized isolates.
Ready to launch a product featuring Epimedium brevicornum (Icariin)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Epimedium brevicornum (Icariin) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Epimedium brevicornum (Icariin) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation